The TET family of proteins: Functions and roles in disease

Journal of Molecular Cell Biology

Volumn 1, Issue 2, 2009, Pages 82-92

  Tan, Adelene Y ^a   Manley, James L ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Arginine methylation; Cancer; EWS; Fusion proteins; Neuronal disease; RNA binding; Splicing; TAF 15; TLS FUS; Transcription; Translocations

Indexed keywords

TRANSCRIPTION FACTOR;

ANIMAL; DNA REPAIR; GENE EXPRESSION REGULATION; GENERAL ASPECTS OF DISEASE; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; NERVE CELL; REVIEW;

ANIMALS; DISEASE; DNA REPAIR; GENE EXPRESSION REGULATION; HUMANS; NEURONS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 77449136874     PISSN: 16742788     EISSN: 17594685     Source Type: Journal    
DOI: 10.1093/jmcb/mjp025     Document Type: Review

References (149)

1. Alex, D., and Lee, K. A. (2005). RGG-boxes of the EWS oncoprotein repress a range of transcriptional activation domains. Nucleic Acids Res. 33, 1323-1331. (Pubitemid 41439925)
2. Aman, P. (1999). Fusion genes in solid tumors. Semin. Cancer Biol. 9, 303-318. (Pubitemid 29429994)
3. Andersson, M. K., Stahlberg, A., Arvidsson, Y., Olofsson, A., Semb, H., Stenman, G., Nilsson, O., and Aman, P. (2008). The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response. BMC Cell Biol. 9, 37.
4. Araya, N., Hirota, K., Shimamoto, Y., Miyagishi, M., Yoshida, E., Ishida, J., Kaneko, S., Kaneko, M., Nakajima, T., and Fukamizu, A. (2003). Cooperative interaction of EWS with CREB-binding protein selectively activates hepatocyte nuclear factor 4-mediated transcription. J. Biol. Chem. 278, 5427-5432. (Pubitemid 36801059)
5. Araya, N., Hiraga, H., Kako, K., Arao, Y., Kato, S., and Fukamizu, A. (2005). Transcriptional down-regulation through nuclear exclusion of EWS methylated by PRMT1. Biochem. Biophys. Res. Commun. 329, 653-660. (Pubitemid 40311793)
6. Arvand, A., and Denny, C. T. (2001). Biology of EWS/ETS fusions in Ewing's family tumors. Oncogene 20, 5747-5754. (Pubitemid 32928112)
7. Aryee, D. N., Sommergruber, W., Muehlbacher, K., Dockhorn-Dworniczak, B., Zoubek, A., and Kovar, H. (2000). Variability in gene expression patterns of Ewing tumor cell lines differing in EWS-FLI1 fusion type. Lab. Invest. 80, 1833-1844. (Pubitemid 32012752)
8. Attwooll, C., Tariq, M., Harris, M., Coyne, J. D., Telford, N., and Varley, J. M. (1999). Identification of a novel fusion gene involving hTAFII68 and CHN from a t (9;17) (q22;q11.2) translocation in an extraskeletal myxoid chondrosarcoma. Oncogene 18, 7599-7601. (Pubitemid 30035062)
9. Azuma, M., Embree, L. J., Sabaawy, H., and Hickstein, D. D. (2007). Ewing sarcoma protein ewsr1 maintains mitotic integrity and proneural cell survival in the zebrafish embryo. PLoS One 2, e979.
10. Bachmaier, R., Aryee, D. N., Jug, G., Kauer, M., Kreppel, M., Lee, K. A., and Kovar, H. (2009). O-GlcNAcylation is involved in the transcriptional activity of EWS-FLI1 in Ewing's sarcoma. Oncogene 28, 1280-1284.
11. Baechtold, H., Kuroda, M., Sok, J., Ron, D., Lopez, B. S., and Akhmedov, A. T. (1999). Human 75-kDa DNA-pairing protein is identical to the pro-oncoprotein TLS/FUS and is able to promote D-loop formation. J. Biol. Chem. 274, 34337-34342. (Pubitemid 129511776)
12. Bailly, R. A., Bosselut, R., Zucman, J., Cormier, F., Delattre, O., Roussel, M., Thomas, G., and Ghysdael, J. (1994). DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t (11;22) translocation in Ewing sarcoma. Mol. Cell. Biol. 14, 3230-3241. (Pubitemid 24132736)
13. Barone, M. V., Crozat, A., Tabaee, A., Philipson, L., and Ron, D. (1994). CHOP (GADD153) and its oncogenic variant, TLS-CHOP, have opposing effects on the induction of G1/S arrest. Genes Dev. 8, 453-464. (Pubitemid 24071185)
14. Belly, A., Moreau-Gachelin, F., Sadoul, R., and Goldberg, Y. (2005). Delocalization of the multifunctional RNA splicing factor TLS/FUS in hippocampal neurones: exclusion from the nucleus and accumulation in dendritic granules and spine heads. Neurosci. Lett. 379, 152-157. (Pubitemid 40544525)
15. Belyanskaya, L. L., Gehrig, P. M., and Gehring, H. (2001). Exposure on cell surface and extensive arginine methylation of Ewing sarcoma (EWS) protein. J. Biol. Chem. 276, 18681-18687.
16. Belyanskaya, L. L., Delattre, O., and Gehring, H. (2003). Expression and subcellular localization of Ewing sarcoma (EWS) protein is affected by the methylation process. Exp. Cell Res. 288, 374-381. (Pubitemid 36959953)
17. Bentley, D. L. (2005). Rules of engagement: co-transcriptional recruitment of pre-mRNA processing factors. Curr. Opin. Cell Biol. 17, 251-256. (Pubitemid 40719913)
18. Bernstein, M., Kovar, H., Paulussen, M., Randall, R. L., Schuck, A., Teot, L. A., and Juergens, H. (2006). Ewing's sarcoma family of tumors: current management. Oncologist 11, 503-519. (Pubitemid 43788277)
19. Bertolotti, A., Lutz, Y., Heard, D. J., Chambon, P., and Tora, L. (1996). hTAF (II) 68, a novel RNA/ssDNA-binding protein with homology to the pro-oncoproteins TLS/FUS and EWS is associated with both TFIID and RNA polymerase II. EMBO J. 15, 5022-5031. (Pubitemid 26315812)
20. Bertolotti, A., Melot, T., Acker, J., Vigneron, M., Delattre, O., and Tora, L. (1998). EWS, but not EWS-FLI-1, is associated with both TFIID and RNA polymerase II: interactions between two members of the TET family, EWS and hTAFII68, and subunits of TFIID and RNA polymerase II complexes. Mol. Cell. Biol. 18, 1489-1497. (Pubitemid 28100914)
21. Bertolotti, A., Bell, B., and Tora, L. (1999). The N-terminal domain of human TAFII68 displays transactivation and oncogenic properties. Oncogene 18, 8000-8010. (Pubitemid 30050561)
22. Bertrand, P., Akhmedov, A. T., Delacote, F., Durrbach, A., and Lopez, B. S. (1999). Human POMp75 is identified as the pro-oncoprotein TLS/FUS: both POMp75 and POMp100 DNA homologous pairing activities are associated to cell proliferation. Oncogene 18, 4515-4521. (Pubitemid 29396659)
23. Beyer, A. L., Christensen, M. E., Walker, B. W., and LeStourgeon, W. M. (1977). Identification and characterization of the packaging proteins of core 40S hnRNP particles. Cell 11, 127-138. (Pubitemid 8126060)
24. Brou, C., Chaudhary, S., Davidson, I., Lutz, Y., Wu, J., Egly, J. M., Tora, L., and Chambon, P. (1993). Distinct TFIID complexes mediate the effect of different transcriptional activators. EMBO J. 12, 489-499. (Pubitemid 23073695)
25. Burd, C. G., and Dreyfuss, G. (1994). Conserved structures and diversity of functions of RNA-binding proteins. Science 265, 615-621. (Pubitemid 24268271)
26. Calvio, C., Neubauer, G., Mann, M., and Lamond, A. I. (1995). Identification of hnRNP P2 as TLS/FUS using electrospray mass spectrometry. RNA 1, 724-733.
27. Chansky, H. A., Hu, M., Hickstein, D. D., and Yang, L. (2001). Oncogenic TLS/ERG and EWS/Fli-1 fusion proteins inhibit RNA splicing mediated by YB-1 protein. Cancer Res. 61, 3586-3590. (Pubitemid 32694966)
28. Chansky, H. A., Barahmand-Pour, F., Mei, Q., Kahn-Farooqi, W., Zielinska-Kwiatkowska, A., Blackburn, M., Chansky, K., Conrad, E. U., 3rd, Bruckner, J. D., Greenlee, T. K., et al. (2004). Targeting of EWS/FLI-1 by RNA interference attenuates the tumor phenotype of Ewing's sarcoma cells in vitro. J. Orthop. Res. 22, 910-917. (Pubitemid 38756277)
29. Crozat, A., Aman, P., Mandahl, N., and Ron, D. (1993). Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 363, 640-644. (Pubitemid 23227627)
30. de Alava, E., Kawai, A., Healey, J. H., Fligman, I., Meyers, P. A., Huvos, A. G., Gerald, W. L., Jhanwar, S. C., Argani, P., Antonescu, C. R., et al. (1998). EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma. J. Clin. Oncol. 16, 1248-1255. (Pubitemid 28175736)
31. de Almeida, S. F., and Carmo-Fonseca, M. (2008). The CTD role in cotranscriptional RNA processing and surveillance. FEBS Lett. 582, 1971-1976.
32. Delattre, O., Zucman, J., Plougastel, B., Desmaze, C., Melot, T., Peter, M., Kovar, H., Joubert, I., de Jong, P., Rouleau, G., et al. (1992). Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359, 162-165.
33. Deloulme, J. C., Prichard, L., Delattre, O., and Storm, D. R. (1997). The prooncoprotein EWS binds calmodulin and is phosphorylated by protein kinase C through an IQ domain. J. Biol. Chem. 272, 27369-27377. (Pubitemid 27452704)
34. Ding, J., Hayashi, M. K., Zhang, Y., Manche, L., Krainer, A. R., and Xu, R. M. (1999). Crystal structure of the two-RRM domain of hnRNP A1 (UP1) complexed with single-stranded telomeric DNA. Genes Dev. 13, 1102-1115. (Pubitemid 29233142)
35. Eliazer, S., Spencer, J., Ye, D., Olson, E., and Ilaria, R. L., Jr. (2003). Alteration of mesodermal cell differentiation by EWS/FLI-1, the oncogene implicated in Ewing's sarcoma. Mol. Cell. Biol. 23, 482-492. (Pubitemid 36050543)
36. Fong, Y. W., and Zhou, Q. (2001). Stimulatory effect of splicing factors on transcriptional elongation. Nature 414, 929-933. (Pubitemid 34024746)
37. Fujii, R., and Takumi, T. (2005). TLS facilitates transport of mRNA encoding an actin-stabilizing protein to dendritic spines. J. Cell Sci. 118, 5755-5765. (Pubitemid 43079269)
38. Fujii, R., Okabe, S., Urushido, T., Inoue, K., Yoshimura, A., Tachibana, T., Nishikawa, T., Hicks, G. G., and Takumi, T. (2005). The RNA binding protein TLS is translocated to dendritic spines by mGluR5 activation and regulates spine morphology. Curr. Biol. 15, 587-593. (Pubitemid 40413401)
39. Fujimura, Y., Siddique, H., Lee, L., Rao, V. N., and Reddy, E. S. (2001). EWS-ATF-1 chimeric protein in soft tissue clear cell sarcoma associates with CREB-binding protein and interferes with p53-mediated trans-activation function. Oncogene 20, 6653-6659. (Pubitemid 33020594)
40. Garcia-Aragoncillo, E., Carrillo, J., Lalli, E., Agra, N., Gomez-Lopez, G., Pestana, A., and Alonso, J. (2008). DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells. Oncogene 27, 6034-6043.
41. Gardiner, M., Toth, R., Vandermoere, F., Morrice, N. A., and Rouse, J. (2008). Identification and characterization of FUS/TLS as a new target of ATM. Biochem. J. 415, 297-307.
42. Gerald, W. L., and Haber, D. A. (2005). The EWS-WT1 gene fusion in desmoplastic small round cell tumor. Semin. Cancer Biol. 15, 197-205.
43. Gonzalez, I., Vicent, S., de Alava, E., and Lecanda, F. (2007). EWS/FLI-1 oncoprotein subtypes impose different requirements for transformation and metastatic activity in a murine model. J. Mol. Med. 85, 1015-1029. (Pubitemid 47282792)
44. Gregory, R. I., Yan, K. P., Amuthan, G., Chendrimada, T., Doratotaj, B., Cooch, N., and Shiekhattar, R. (2004). The Microprocessor complex mediates the genesis of microRNAs. Nature 432, 235-240. (Pubitemid 39545855)
45. Guipaud, O., Guillonneau, F., Labas, V., Praseuth, D., Rossier, J., Lopez, B., and Bertrand, P. (2006). An in vitro enzymatic assay coupled to proteomics analysis reveals a new DNA processing activity for Ewing sarcoma and TAF (II) 68 proteins. Proteomics 6, 5962-5972. (Pubitemid 44851382)
46. Hahm, K. B., Cho, K., Lee, C., Im, Y. H., Chang, J., Choi, S. G., Sorensen, P. H., Thiele, C. J., and Kim, S. J. (1999). Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein. Nat. Genet. 23, 222-227. (Pubitemid 29455398)
47. Hallier, M., Lerga, A., Barnache, S., Tavitian, A., and Moreau-Gachelin, F. (1998). The transcription factor Spi-1/PU.1 interacts with the potential splicing factor TLS. J. Biol. Chem. 273, 4838-4842. (Pubitemid 28108632)
48. Hicks, G. G., Singh, N., Nashabi, A., Mai, S., Bozek, G., Klewes, L., Arapovic, D., White, E. K., Koury, M. J., Oltz, E. M., et al. (2000). Fus deficiency in mice results in defective B-lymphocyte development and activation, high levels of chromosomal instability and perinatal death. Nat. Genet. 24, 175-179. (Pubitemid 30094720)
49. Hirose, Y., and Manley, J. L. (2000). RNA polymerase II and the integration of nuclear events. Genes Dev. 14, 1415-1429. (Pubitemid 30421835)
50. Hosaka, T., Kanoe, H., Nakayama, T., Murakami, H., Yamamoto, H., Nakamata, T., Tsuboyama, T., Oka, M., Kasai, M., Sasaki, M. S., et al. (2000). Translin binds to the sequences adjacent to the breakpoints of the TLS and CHOP genes in liposarcomas with translocation t (12;6). Oncogene 19, 5821-5825.
51. Hu, H. M., Zielinska-Kwiatkowska, A., Munro, K., Wilcox, J., Wu, D. Y., Yang, L., and Chansky, H. A. (2008). EWS/FLI1 suppresses retinoblastoma protein function and senescence in Ewing's sarcoma cells. J. Orthop. Res. 26, 886-893.
52. Iko, Y., Kodama, T. S., Kasai, N., Oyama, T., Morita, E. H., Muto, T., Okumura, M., Fujii, R., Takumi, T., Tate, S., et al. (2004). Domain architectures and characterization of an RNA-binding protein, TLS. J. Biol. Chem. 279, 44834-44840. (Pubitemid 39430895)
53. Immanuel, D., Zinszner, H., and Ron, D. (1995). Association of SARFH (sarcoma-associated RNA-binding fly homolog) with regions of chromatin transcribed by RNA polymerase II. Mol. Cell. Biol. 15, 4562-4571.
54. Jaishankar, S., Zhang, J., Roussel, M. F., and Baker, S. J. (1999). Transforming activity of EWS/FLI is not strictly dependent upon DNA-binding activity. Oncogene 18, 5592-5597. (Pubitemid 29481506)
55. Janknecht, R. (2005). EWS-ETS oncoproteins: the linchpins of Ewing tumors. Gene 363, 1-14. (Pubitemid 41691887)
56. Jobert, L., Argentini, M., and Tora, L. (2009a). PRMT1 mediated methylation of TAF15 is required for its positive gene regulatory function. Exp. Cell Res. 315, 1273-1286.
57. Jobert, L., Pinzon, N., Van Herreweghe, E., Jady, B. E., Guialis, A., Kiss, T., and Tora, L. (2009b). Human U1 snRNA forms a new chromatin-associated snRNP with TAF15. EMBO Rep. 10, 494-500.
58. Kameoka, S., Duque, P., and Konarska, M. M. (2004). p54 (nrb) associates with the 50 splice site within large transcription/splicing complexes. EMBO J. 23, 1782-1791. (Pubitemid 38649641)
59. Kanai, Y., Dohmae, N., and Hirokawa, N. (2004). Kinesin transports RNA: isolation and characterization of an RNA-transporting granule. Neuron 43, 513-525. (Pubitemid 39094678)
60. Kanoe, H., Nakayama, T., Hosaka, T., Murakami, H., Yamamoto, H., Nakashima, Y., Tsuboyama, T., Nakamura, T., Ron, D., Sasaki, M. S., et al. (1999). Characteristics of genomic breakpoints in TLS-CHOP translocations in liposarcomas suggest the involvement of Translin and topoisomerase II in the process of translocation. Oncogene 18, 721-729. (Pubitemid 29080329)
61. Kauer, M., Ban, J., Kofler, R., Walker, B., Davis, S., Meltzer, P., and Kovar, H. (2009). A molecular function map of Ewing's sarcoma. PLoS One 4, e5415.
62. Klevernic, I. V., Morton, S., Davis, R. J., and Cohen, P. (2008). Phosphorylation of EWS and EWS-Fli1 in response to DNA damage. Biochem. J. 418, 625-634.
63. Klint, P., Hellman, U., Wernstedt, C., Aman, P., Ron, D., and Claesson-Welsh, L. (2004). Translocated in liposarcoma (TLS) is a substrate for fibroblast growth factor receptor-1. Cell Signal. 16, 515-520. (Pubitemid 38058634)
64. Kornblihtt, A. R., de la Mata, M., Fededa, J. P., Munoz, M. J., and Nogues, G. (2004). Multiple links between transcription and splicing. RNA 10, 1489-1498. (Pubitemid 39288183)
65. Kovar, H. (2005). Context matters: the hen or egg problem in Ewing's sarcoma. Semin. Cancer Biol. 15, 189-196.
66. Kuroda, M., Wang, X., Sok, J., Yin, Y., Chung, P., Giannotti, J. W., Jacobs, K. A., Fitz, L. J., Murtha-Riel, P., Turner, K. J., et al. (1999). Induction of a secreted protein by the myxoid liposarcoma oncogene. Proc. Natl. Acad. Sci. USA 96, 5025-5030. (Pubitemid 29214529)
67. Kuroda, M., Sok, J., Webb, L., Baechtold, H., Urano, F., Yin, Y., Chung, P., de Rooij, D. G., Akhmedov, A., Ashley, T., et al. (2000). Male sterility and enhanced radiation sensitivity in TLS (-/-) mice. EMBO J. 19, 453-462. (Pubitemid 30072615)
68. Kwiatkowski, T. J., Jr., Bosco, D. A., Leclerc, A. L., Tamrazian, E., Vanderburg, C. R., Russ, C., Davis, A., Gilchrist, J., Kasarskis, E. J., Munsat, T., et al. (2009). Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323, 1205-1208.
69. Ladomery, M., and Dellaire, G. (2002). Multifunctional zinc finger proteins in development and disease. Ann. Hum. Genet. 66, 331-342. (Pubitemid 36004223)
70. Lee, K. A. (2007). Ewings family oncoproteins: drunk, disorderly and in search of partners. Cell Res. 17, 286-288. (Pubitemid 46639926)
71. Lee, H. J., Kim, S., Pelletier, J., and Kim, J. (2004). Stimulation of hTAFII68 (NTD)-mediated transactivation by v-Src. FEBS Lett. 564, 188-198. (Pubitemid 38490723)
72. Lee, J., Rhee, B. K., Bae, G. Y., Han, Y. M., and Kim, J. (2005). Stimulation of Oct-4 activity by Ewing's sarcoma protein. Stem Cells 23, 738-751. (Pubitemid 40791789)
73. Lerga, A., Hallier, M., Delva, L., Orvain, C., Gallais, I., Marie, J., and Moreau-Gachelin, F. (2001). Identification of an RNA binding specificity for the potential splicing factor TLS. J. Biol. Chem. 276, 6807-6816.
74. Lessnick, S. L., Dacwag, C. S., and Golub, T. R. (2002). The Ewing's sarcoma oncoprotein EWS/FLI induces a p53-dependent growth arrest in primary human fibroblasts. Cancer Cell 1, 393-401. (Pubitemid 41039140)
75. Li, K. K., and Lee, K. A. (2000). Transcriptional activation by the Ewing's sarcoma (EWS) oncogene can be cis-repressed by the EWS RNA-binding domain. J. Biol. Chem. 275, 23053-23058. (Pubitemid 30646195)
76. Li, X. Y., and Green, M. R. (1998). The HIV-1 Tat cellular coactivator Tat-SF1 is a general transcription elongation factor. Genes Dev. 12, 2992-2996. (Pubitemid 28469301)
77. Li, H., Watford, W., Li, C., Parmelee, A., Bryant, M. A., Deng, C., O'Shea, J., and Lee, S. B. (2007). Ewing sarcoma gene EWS is essential for meiosis and B lymphocyte development. J. Clin. Invest. 117, 1314-1323. (Pubitemid 46718419)
78. Lin, P. P., Brody, R. I., Hamelin, A. C., Bradner, J. E., Healey, J. H., and Ladanyi, M. (1999). Differential transactivation by alternative EWS-FLI1 fusion proteins correlates with clinical heterogeneity in Ewing's sarcoma. Cancer Res. 59, 1428-1432. (Pubitemid 29160104)
79. Liu, Q., and Dreyfuss, G. (1995). In vivo and in vitro arginine methylation of RNA-binding proteins. Mol. Cell. Biol. 15, 2800-2808.
80. Manley, J. L. (2002). Nuclear coupling: RNA processing reaches back to transcription. Nat. Struct. Biol. 9, 790-791. (Pubitemid 35257773)
81. Martini, A., La Starza, R., Janssen, H., Bilhou-Nabera, C., Corveleyn, A., Somers, R., Aventin, A., Foa, R., Hagemeijer, A., Mecucci, C., et al. (2002). Recurrent rearrangement of the Ewing's sarcoma gene, EWSR1, or its homologue, TAF15, with the transcription factor CIZ/NMP4 in acute leukemia. Cancer Res. 62, 5408-5412.
82. May, W. A., Arvand, A., Thompson, A. D., Braun, B. S., Wright, M., and Denny, C. T. (1997). EWS/FLI1-induced manic fringe renders NIH 3T3 cells tumorigenic. Nat. Genet. 17, 495-497. (Pubitemid 27518406)
83. Meissner, M., Lopato, S., Gotzmann, J., Sauermann, G., and Barta, A. (2003). Proto-oncoprotein TLS/FUS is associated to the nuclear matrix and complexed with splicing factors PTB, SRm160, and SR proteins. Exp. Cell Res. 283, 184-195. (Pubitemid 36269024)
84. Melot, T., Dauphinot, L., Sevenet, N., Radvanyi, F., and Delattre, O. (2001). Characterization of a new brain-specific isoform of the EWS oncoprotein. Eur. J. Biochem. 268, 3483-3489. (Pubitemid 32862941)
85. Mendiola, M., Carrillo, J., Garcia, E., Lalli, E., Hernandez, T., de Alava, E., Tirode, F., Delattre, O., Garcia-Miguel, P., Lopez-Barea, F., et al. (2006). The orphan nuclear receptor DAX1 is up-regulated by the EWS/FLI1 oncoprotein and is highly expressed in Ewing tumors. Int. J. Cancer 118, 1381-1389.
86. Morohoshi, F., Arai, K., Takahashi, E. I., Tanigami, A., and Ohki, M. (1996). Cloning and mapping of a human RBP56 gene encoding a putative RNA binding protein similar to FUS/TLS and EWS proteins. Genomics 38, 51-57. (Pubitemid 26423913)
87. Ng, K. P., Potikyan, G., Savene, R. O., Denny, C. T., Uversky, V. N., and Lee, K. A. (2007). Multiple aromatic side chains within a disordered structure are critical for transcription and transforming activity of EWS family oncoproteins. Proc. Natl Acad. Sci. USA 104, 479-484. (Pubitemid 46123051)
88. Ng, K. P., Li, K. K., and Lee, K. A. (2009). In vitro activity of the EWS oncogene transcriptional activation domain. Biochemistry 48, 2849-2857.
89. Nishimori, H., Sasaki, Y., Yoshida, K., Irifune, H., Zembutsu, H., Tanaka, T., Aoyama, T., Hosaka, T., Kawaguchi, S., Wada, T., et al. (2002). The Id2 gene is a novel target of transcriptional activation by EWS-ETS fusion proteins in Ewing family tumors. Oncogene 21, 8302-8309. (Pubitemid 35477870)
90. Oda, Y., and Tsuneyoshi, M. (2009). Recent advances in the molecular pathology of soft tissue sarcoma: implications for diagnosis, patient prognosis, and molecular target therapy in the future. Cancer Sci. 100, 200-208.
91. Ohno, T., Ouchida, M., Lee, L., Gatalica, Z., Rao, V. N., and Reddy, E. S. (1994). The EWS gene, involved in Ewing family of tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors, codes for an RNA binding protein with novel regulatory domains. Oncogene 9, 3087-3097. (Pubitemid 24296791)
92. Oikawa, T., and Yamada, T. (2003). Molecular biology of the Ets family of transcription factors. Gene 303, 11-34. (Pubitemid 36151767)
93. Olsen, R. J., Tarantolo, S. R., and Hinrichs, S. H. (2002). Molecular approaches to sarcoma therapy. Sarcoma 6, 27-42. (Pubitemid 34620886)
94. Osuna, D., and de Alava, E. (2009). Molecular pathology of sarcomas. Rev. Recent Clin. Trials 4, 12-26.
95. Pahlich, S., Bschir, K., Chiavi, C., Belyanskaya, L., and Gehring, H. (2005). Different methylation characteristics of protein arginine methyltransferase 1 and 3 toward the Ewing sarcoma protein and a peptide. Proteins 61, 164-175. (Pubitemid 41262925)
96. Pahlich, S., Zakaryan, R. P., and Gehring, H. (2008). Identification of proteins interacting with protein arginine methyltransferase 8: the Ewing sarcoma (EWS) protein binds independent of its methylation state. Proteins 72, 1125-1137.
97. Panagopoulos, I., Lassen, C., Isaksson, M., Mitelman, F., Mandahl, N., and Aman, P. (1997). Characteristic sequence motifs at the breakpoints of the hybrid genes FUS/CHOP, EWS/CHOP and FUS/ERG in myxoid liposarcoma and acute myeloid leukemia. Oncogene 15, 1357-1362. (Pubitemid 27429752)
98. Panagopoulos, I., Mencinger, M., Dietrich, C. U., Bjerkehagen, B., Saeter, G., Mertens, F., Mandahl, N., and Heim, S. (1999). Fusion of the RBP56 and CHN genes in extraskeletal myxoid chondrosarcomas with translocation t (9;17) (q22;q11). Oncogene 18, 7594-7598. (Pubitemid 30035061)
99. Perez-Losada, J., Pintado, B., Gutierrez-Adan, A., Flores, T., Banares-Gonzalez, B., del Campo, J. C., Martin-Martin, J. F., Battaner, E., and Sanchez-Garcia, I. (2000a). The chimeric FUS/TLS-CHOP fusion protein specifically induces liposarcomas in transgenic mice. Oncogene 19, 2413-2422. (Pubitemid 30323474)
100. Perez-Losada, J., Sanchez-Martin, M., Rodriguez-Garcia, M. A., Perez-Mancera, P. A., Pintado, B., Flores, T., Battaner, E., and Sanchez-Garcia, I. (2000b). Liposarcoma initiated by FUS/TLS-CHOP: the FUS/TLS domain plays a critical role in the pathogenesis of liposarcoma. Oncogene 19, 6015-6022. (Pubitemid 32040990)
101. Perez-Mancera, P. A., Vicente-Duenas, C., Gonzalez-Herrero, I., Sanchez-Martin, M., Flores-Corral, T., and Sanchez-Garcia, I. (2007). Fat-specific FUS-DDIT3-transgenic mice establish PPARgamma inactivation is required to liposarcoma development. Carcinogenesis 28, 2069-2073. (Pubitemid 47543364)
102. Perez-Mancera, P. A., Bermejo-Rodriguez, C., Sanchez-Martin, M., Abollo-Jimenez, F., Pintado, B., and Sanchez-Garcia, I. (2008). FUS-DDIT3 prevents the development of adipocytic precursors in liposarcoma by repressing PPARgamma and C/EBPalpha and activating eIF4E. PLoS One 3, e2569.
103. Perrotti, D., Bonatti, S., Trotta, R., Martinez, R., Skorski, T., Salomoni, P., Grassilli, E., Lozzo, R. V., Cooper, D. R., and Calabretta, B. (1998). TLS/FUS, a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL-mediated leukemogenesis. EMBO J. 17, 4442-4455. (Pubitemid 28362633)
104. Perrotti, D., Iervolino, A., Cesi, V., Cirinna, M., Lombardini, S., Grassilli, E., Bonatti, S., Claudio, P. P., and Calabretta, B. (2000). BCR-ABL prevents c-jun-mediated and proteasome-dependent FUS (TLS) proteolysis through a protein kinase CbetaII-dependent pathway. Mol. Cell. Biol. 20, 6159-6169. (Pubitemid 30613063)
105. Petermann, R., Mossier, B. M., Aryee, D. N., Khazak, V., Golemis, E. A., and Kovar, H. (1998). Oncogenic EWS-Fli1 interacts with hsRPB7, a subunit of human RNA polymerase II. Oncogene 17, 603-610. (Pubitemid 28401029)
106. Pieler, T., and Theunissen, O. (1993). TFIIIA: nine fingers-three hands? Trends Biochem. Sci. 18, 226-230.
107. Powers, C. A., Mathur, M., Raaka, B. M., Ron, D., and Samuels, H. H. (1998). TLS (translocated-in-liposarcoma) is a high-affinity interactor for steroid, thyroid hormone, and retinoid receptors. Mol. Endocrinol. 12, 4-18. (Pubitemid 28124775)
108. Prieur, A., Tirode, F., Cohen, P., and Delattre, O. (2004). EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3. Mol. Cell. Biol. 24, 7275-7283. (Pubitemid 39014452)
109. Rabbitts, T. H., Forster, A., Larson, R., and Nathan, P. (1993). Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t (12;16) in malignant liposarcoma. Nat. Genet. 4, 175-180. (Pubitemid 23179103)
110. Rappsilber, J., Ryder, U., Lamond, A. I., and Mann, M. (2002). Large-scale proteomic analysis of the human spliceosome. Genome Res. 12, 1231-1245. (Pubitemid 41264425)
111. Rappsilber, J., Friesen, W. J., Paushkin, S., Dreyfuss, G., and Mann, M. (2003). Detection of arginine dimethylated peptides by parallel precursor ion scanning mass spectrometry in positive ion mode. Anal. Chem. 75, 3107-3114. (Pubitemid 36830440)
112. Riggi, N., Cironi, L., Suva, M. L., and Stamenkovic, I. (2007). Sarcomas: genetics, signalling, and cellular origins. Part 1: the fellowship of TET. J. Pathol. 213, 4-20. (Pubitemid 47354561)
113. Riggi, N., and Stamenkovic, I. (2007). The biology of Ewing sarcoma. Cancer Lett. 254, 1-10. (Pubitemid 47058800)
114. Rossow, K. L., and Janknecht, R. (2001). The Ewing's sarcoma gene product functions as a transcriptional activator. Cancer Res. 61, 2690-2695. (Pubitemid 32685856)
115. Rual, J. F., Venkatesan, K., Hao, T., Hirozane-Kishikawa, T., Dricot, A., Li, N., Berriz, G. F., Gibbons, F. D., Dreze, M., Ayivi-Guedehoussou, N., et al. (2005). Towards a proteome-scale map of the human protein-protein interaction network. Nature 437, 1173-1178. (Pubitemid 41509356)
116. Savola, S., Klami, A., Tripathi, A., Niini, T., Serra, M., Picci, P., Kaski, S., Zambelli, D., Scotlandi, K., and Knuutila, S. (2009). Combined use of expression and CGH arrays pinpoints novel candidate genes in Ewing sarcoma family of tumors. BMC Cancer 9, 17.
117. Shin, C., and Manley, J. L. (2002). The SR protein SRp38 represses splicing in M phase cells. Cell 111, 407-417. (Pubitemid 35341393)
118. Sjogren, H., Meis-Kindblom, J., Kindblom, L. G., Aman, P., and Stenman, G. (1999). Fusion of the EWS-related gene TAF2N to TEC in extraskeletal myxoid chondrosarcoma. Cancer Res. 59, 5064-5067. (Pubitemid 29503959)
119. Smith, R., Owen, L. A., Trem, D. J., Wong, J. S., Whangbo, J. S., Golub, T. R., and Lessnick, S. L. (2006). Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma. Cancer Cell 9, 405-416. (Pubitemid 43668735)
120. Stallcup, M. R. (2001). Role of protein methylation in chromatin remodeling and transcriptional regulation. Oncogene 20, 3014-3020. (Pubitemid 32553555)
121. Stolow, D. T., and Haynes, S. R. (1995). Cabeza, a Drosophila gene encoding a novel RNA binding protein, shares homology with EWS and TLS, two genes involved in human sarcoma formation. Nucleic Acids Res. 23, 835-843.
122. Takahashi, A., Higashino, F., Aoyagi, M., Yoshida, K., Itoh, M., Kyo, S., Ohno, T., Taira, T., Ariga, H., Nakajima, K., et al. (2003). EWS/ETS fusions activate telomerase in Ewing's tumors. Cancer Res. 63, 8338-8344. (Pubitemid 37549487)
123. Tanaka, K., Iwakuma, T., Harimaya, K., Sato, H., and Iwamoto, Y. (1997). EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells. J. Clin. Invest. 99, 239-247. (Pubitemid 27053464)
124. Thelin-Jarnum, S., Lassen, C., Panagopoulos, I., Mandahl, N., and Aman, P. (1999). Identification of genes differentially expressed in TLS-CHOP carrying myxoid liposarcomas. Int. J. Cancer 83, 30-33. (Pubitemid 29409472)
125. Thomas, G. R., and Latchman, D. S. (2002). The pro-oncoprotein EWS (Ewing's Sarcoma protein) interacts with the Brn-3a POU transcription factor and inhibits its ability to activate transcription. Cancer Biol. Ther. 1, 428-432.
126. Thompson, A. D., Braun, B. S., Arvand, A., Stewart, S. D., May, W. A., Chen, E., Korenberg, J., and Denny, C. (1996). EAT-2 is a novel SH2 domain containing protein that is up regulated by Ewing's sarcoma EWS/FLI1 fusion gene. Oncogene 13, 2649-2658. (Pubitemid 27046120)
127. Tora, L. (2002). A unified nomenclature for TATA box binding protein (TBP)-associated factors (TAFs) involved in RNA polymerase II transcription. Genes Dev. 16, 673-675. (Pubitemid 34274035)
128. Tuerk, C., and Gold, L. (1990). Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249, 505-510.
129. Uren, A., Tcherkasskaya, O., and Toretsky, J. A. (2004). Recombinant EWS-FLI1 oncoprotein activates transcription. Biochemistry 43, 13579-13589. (Pubitemid 39391158)
130. Vance, C., Rogelj, B., Hortobagyi, T., De Vos, K. J., Nishimura, A. L., Sreedharan, J., Hu, X., Smith, B., Ruddy, D., Wright, P., et al. (2009). Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323, 1208-1211.
131. Wang, X., Arai, S., Song, X., Reichart, D., Du, K., Pascual, G., Tempst, P., Rosenfeld, M. G., Glass, C. K., and Kurokawa, R. (2008). Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature 454, 126-130. (Pubitemid 351934270)
132. Welford, S. M., Hebert, S. P., Deneen, B., Arvand, A., and Denny, C. T. (2001). DNA binding domain-independent pathways are involved in EWS/FLI1-mediated oncogenesis. J. Biol. Chem. 276, 41977-41984.
133. Wu, S., and Green, M. R. (1997). Identification of a human protein that recognizes the 30 splice site during the second step of pre-mRNA splicing. EMBO J. 16, 4421-4432. (Pubitemid 27298195)
134. Xia, S. J., and Barr, F. G. (2005). Chromosome translocations in sarcomas and the emergence of oncogenic transcription factors. Eur. J. Cancer 41, 2513-2527. (Pubitemid 41540627)
135. Xiang, H., Wang, J., Hisaoka, M., and Zhu, X. (2008). Characteristic sequence motifs located at the genomic breakpoints of the translocation t (12;16) and t (12;22) in myxoid liposarcoma. Pathology 40, 547-552.
136. Yang, L., Embree, L. J., Tsai, S., and Hickstein, D. D. (1998). Oncoprotein TLS interacts with serine-arginine proteins involved in RNA splicing. J. Biol. Chem. 273, 27761-27764. (Pubitemid 28496059)
137. Yang, L., Chansky, H. A., and Hickstein, D. D. (2000a). EWS. Fli-1 fusion protein interacts with hyperphosphorylated RNA polymerase II and interferes with serine-arginine protein-mediated RNA splicing. J. Biol. Chem. 275, 37612-37618. (Pubitemid 32004872)
138. Yang, L., Embree, L. J., and Hickstein, D. D. (2000b). TLS-ERG leukemia fusion protein inhibits RNA splicing mediated by serine-arginine proteins. Mol. Cell. Biol. 20, 3345-3354. (Pubitemid 30243880)
139. Yi, H., Fujimura, Y., Ouchida, M., Prasad, D. D., Rao, V. N., and Reddy, E. S. (1997). Inhibition of apoptosis by normal and aberrant Fli-1 and erg proteins involved in human solid tumors and leukemias. Oncogene 14, 1259-1268. (Pubitemid 27151983)
140. Yu, Z., and Hecht, N. B. (2008). The DNA/RNA-binding protein, translin, binds microRNA122a and increases its in vivo stability. J. Androl. 29, 572-579.
141. Zhang, D., Paley, A. J., and Childs, G. (1998). The transcriptional repressor ZFM1 interacts with and modulates the ability of EWS to activate transcription. J. Biol. Chem. 273, 18086-18091. (Pubitemid 28334724)
142. Zhou, H., and Lee, K. A. (2001). An hsRPB4/7-dependent yeast assay for transactivation by the EWS oncogene. Oncogene 20, 1519-1524. (Pubitemid 32291202)
143. Zhou, Q., and Sharp, P. A. (1996). Tat-SF1: cofactor for stimulation of transcriptional elongation by HIV-1 Tat. Science 274, 605-610. (Pubitemid 26360439)
144. Zhou, Z., Licklider, L. J., Gygi, S. P., and Reed, R. (2002). Comprehensive proteomic analysis of the human spliceosome. Nature 419, 182-185. (Pubitemid 35025448)
145. Zinszner, H., Albalat, R., and Ron, D. (1994). A novel effector domain
146. Zinszner, H., Immanuel, D., Yin, Y., Liang, F. X., and Ron, D. (1997a). A topogenic role for the oncogenic N-terminus of TLS: nucleolar localization when transcription is inhibited. Oncogene 14, 451-461. (Pubitemid 27087108)
147. Zinszner, H., Sok, J., Immanuel, D., Yin, Y., and Ron, D. (1997b). TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling. J. Cell Sci. 110 (Pt 15), 1741-1750. (Pubitemid 27352853)
148. Zoubek, A., Dockhorn-Dworniczak, B., Delattre, O., Christiansen, H., Niggli, F., Gatterer-Menz, I., Smith, T. L., Jurgens, H., Gadner, H., and Kovar, H. (1996). Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients? J. Clin. Oncol. 14, 1245-1251. (Pubitemid 26105532)
149. Zucman, J., Melot, T., Desmaze, C., Ghysdael, J., Plougastel, B., Peter, M., Zucker, J. M., Triche, T. J., Sheer, D., Turc-Carel, C., et al. (1993). Combinatorial generation of variable fusion proteins in the Ewing family of tumours. EMBO J. 12, 4481-4487. (Pubitemid 23330254)